4-Acetamidophenyl acetate, 98.0%, 25g

{[1-(2-methoxyphenyl)-1H-pyrazol-4-yl]methyl}amine dihydrochloride, 95.0%, 1g

1H-1,2,4-Triazole-3,5-diamine, 95.0%, 500g

valerenic acid, with analyt. Documents, 100 mg, glass packaging

(S)-4-Oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid, 95+%, 1g

6-nitro-3-(prop-2-yn-1-yl)benzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 250mg

(2,1,3-Benzoxadiazol-5-yl)methanol, 97%, 250mg

1-N-Boc-4-(5-Bromopyrimidin-2-yl)piperazine, 95.0%, 25g

(4-Methylmorpholin-3-yl)methanol, 95.0%, 1g

Methyl 1-Boc-3-methyl-4-oxo-piperidine-3-carboxylate, 95.0%, 10g

2,3-Dimethylhydroquinone, 95.0%, 1g

Decan-2-ol, 98%, 25g

4-(2,6-Dichloro-phenyl)-thiazol-2-ylamine, 1g